The Standard organises the transfer/amalgamation process around four core concepts: APRA pre‑clearance, public disclosure, policyholder notice and judicial confirmation. Each carries specific documentary, timing and accessibility rules.

APRA pre‑clearance: Before the notice of intention or the APRA‑approved summary can be published or distributed, the insurer must provide to APRA a copy of the scheme and any actuarial reports on which the scheme is based (paras 4-6). The attachment records that at this stage APRA may arrange an independent actuarial review under s 17D of the Act (attachment table, Order 1). APRA must also approve the form of the notice of intention and the summary (paras 7-11; paras 12-15).

Public disclosure: The Standard requires the insurer to publish the scheme documents, including actuarial reports, on the websites of insurers to be bound by the scheme in a manner that is accessible and reasonably prominent, from the time a notice of intention is published up until the date of the scheme’s confirmation hearing (para 16). The Standard ties the earliest permissible date for a Court application to the period the scheme documents have been publicly available on the insurer’s website (para 17).

Policyholder notice: A specifically APRA‑approved summary must be provided to every affected policyholder prior to, or at the same time as, publication of the scheme (paras 12-15). The Standard prescribes minimum content for the approved summary, including the identity of the transferee insurer, the effect of the transfer on rights and liabilities, any action the policyholder must take, where to obtain further information, and that policyholders have the right to attend and be heard by the Federal Court if they believe the scheme may detrimentally affect policyholders as a whole (paras 12-15).

Judicial confirmation and post‑confirmation reporting: The scheme normally requires Federal Court confirmation (para 2). The Standard sets minimum waiting periods before an application may be made: at least one day after the scheme documents have been published on the insurer’s website for at least 15 days and, unless the Court dispenses, 15 days after the approved summary has been given to every affected policyholder (para 17). If the Court confirms the scheme, the transferee insurer must supply APRA, within 30 days of completion, certified copies of the scheme and Court order, a before/after statement of assets and liabilities, and a director’s statutory declaration identifying payments made, estimated payments and a belief that no other payments have been or will be made with the knowledge of a party to the transfer (paras 18-20). APRA can grant an extension of up to 30 days if satisfied an insurer cannot reasonably meet the 30‑day deadline, and must respond to an extension request within 14 days (para 20).

Other interacting concepts: The Standard expressly incorporates the Insurance Acquisitions and Takeovers Act 1991 notification requirement where transfers amount to 15% or more of the transferring insurer’s premiums or outstanding claims liabilities (para 3). The attachment maps programmatic steps against specific provisions of the Act (e.g. 17C(2)(a),(b),(c); 17E; 17F; 17I), signalling that the Standard operationalises statutory requirements rather than creating a wholly separate regime.

Primary regulated entities: The Standard applies to all general insurers authorised under the Insurance Act 1973 (para 1; Interpretation). Both the transferring insurer and any insurer receiving transferred business (the transferee) are subject to obligations under the Standard , pre‑application documentary obligations fall on the transferring insurer (paras 4-6), while post‑confirmation lodgement obligations attach to the insurer to which business is transferred or which is amalgamated (paras 18-20).

Policyholders: “Affected policyholders” are the intended recipients of the approved summary and thus identified as a protected constituency. The Standard requires the approved summary to be given to every affected policyholder before or at the time the scheme is published (para 12(1) and final sentence of para 15). The approved summary must inform policyholders of the effect of the transfer, any action required of them, and their right to attend and request to be heard by the Federal Court if they consider their interests may be detrimentally affected (para 13(7)). Therefore policyholders are a direct target of the disclosure and timing rules.

APRA and the Federal Court: APRA is the gatekeeper for pre‑publication review and approval of scheme summaries and notices, can arrange independent actuarial reviews (attachment), and receives post‑completion certified documents and declarations (paras 4-6; paras 18-20). The Federal Court is the body empowered to confirm schemes under the Act; the Standard conditions access to Court proceedings on compliance with APRA requirements (para 2; paras 17). The Standard notes one exception: a transfer may be undertaken in response to a direction from APRA rather than under a Court‑confirmed scheme (para 2).

Other statutory regimes and interested third parties: The Standard explicitly interacts with the Insurance Acquisitions and Takeovers Act 1991 when transfers amount to 15% or more of premiums or outstanding claims liabilities, creating a compulsory notification obligation under IATA (para 3). Beyond that, the public and “interested members of the public” are named as constituencies whom the disclosure rules are designed to inform (attachment Objectives). In practice, creditors, reinsurers, brokers and rating agencies are likely to have practical interest in the scheme documents and actuarial reports, because the Standard mandates publication of those materials on insurer websites (para 16).

Directors and officers: The Standard requires a statutory declaration by a Director after completion, detailing payments made or estimated and stating the director’s reasonable belief that no other payment has been or will be made by, or with the knowledge of, a party to the transfer (para 18(1)(b)(i)-(ii) and para 18(1)(b)(1)). That imposes a personal attestation duty on directors of transferee insurers and creates record and disclosure obligations that bear on board oversight and governance.

Service providers: Actuaries and legal advisers are implicated by the Standard. Actuarial reports must accompany scheme documents to APRA and be published with the scheme on insurer websites (paras 4-6; para 16). The attachment suggests APRA may commission independent actuarial reviews under s 17D (attachment Order 1).

Duties

• Provide scheme and actuarial reports to APRA prior to publishing a notice of intention and prior to giving the APRA‑approved summary to affected policyholders (paras 4-6). The attachment confirms this step and notes APRA’s ability to arrange an independent actuarial review under s 17D (attachment Order 1).
• Secure APRA approval of the summary of the scheme and the form of the notice of intention before publication (paras 7-11; paras 12-15).
• Publish a notice of intention in an APRA‑approved form and in a manner that is accessible to the public and reasonably prominent; publish a copy of the scheme at the same time (paras 7-11; para 16).
• Make the scheme documents, including the actuarial reports, accessible and prominently displayed on the websites of each insurer to be bound by the scheme from the time the notice of intention is published until the date of the confirmation hearing (para 16).
• Ensure the approved summary is given to every affected policyholder before or at the same time the scheme is published (para 12(1); final sentence of para 15).
• Observe minimum waiting periods before applying to the Federal Court: one day after the scheme documents have been published on the insurer’s website for at least 15 days and, unless the Court dispenses with the requirement, 15 days after the approved summary has been given to policyholders (para 17).
• After Court confirmation and completion of the transfer or amalgamation, the transferee insurer must lodge with APRA within 30 days: a certified copy of the scheme; the Court order confirming the scheme; a statement of assets and liabilities of each insurer before and after the transfer; and a director’s statutory declaration detailing payments made and estimated and stating belief that no other payment has been or will be made by, or with the knowledge of, a party to the transfer (paras 18-20). The insurer may apply to APRA for an extension before the 30‑day period expires; APRA must decide within 14 days and may grant up to 30 days more (para 20).

Rights

• Policyholders retain procedural rights under the scheme process: the approved summary must inform them that they have the right to attend the Federal Court and request to be heard if they believe the scheme could detrimentally affect policyholders as a whole (para 13(7)). That is a procedural protection embedded in the approved summary content requirements.
• The Court retains discretion to dispense with the 15‑day requirement for giving the approved summary to policyholders under paragraph 17C(2)(c) of the Act; the Standard acknowledges that an application may be made earlier if the Court dispenses with compliance (para 17).
• Insurers may apply to APRA for an extension of time to lodge post‑confirmation documents, and APRA has a duty to respond to an extension request within 14 days and may grant up to 30 days further (para 20).

Operational and governance duties

• Directors of the transferee insurer must provide a statutory declaration with detailed payments information and a statement that they reasonably believe no other payments have been or will be made by, or with the knowledge of, a party to the transfer or amalgamation (para 18(1)(b)). That duty places an evidentiary and governance obligation on directors and requires contemporaneous records.

Gatekeeping role of APRA

• APRA is given an explicit approval and supervisory role prior to publication and application to the Court (paras 4-15), and a post‑confirmation reporting and verification role (paras 18-20). The Standard operationalises APRA’s authority under the Act and contemplates APRA‑initiated actuarial review (attachment).

Limitations on operation

• The Standard prescribes procedural prerequisites to making an application to the Federal Court. Non‑compliance with these prerequisites will prevent the insurer from legally making an application unless the Court dispenses with specific statutory requirements as noted (para 17).

The Standard itself does not prescribe express monetary penalties, licence suspensions, criminal sanctions or administrative fines in the text supplied. Instead, it operates through procedural conditions, APRA supervisory authority, and statutory cross‑references which create legal consequences through other mechanisms.

Procedural gating and Court jurisdiction: The most immediate enforcement effect is that the statutory and prudential prerequisites enforced by APRA are conditions precedent to the insurer being entitled to apply to the Federal Court for confirmation of a scheme. The Standard repeatedly states that an application to the Court cannot be made unless, among other things, APRA has received the scheme and actuarial reports and the APRA‑approved summary has been given to affected policyholders (paras 4-6; paras 12-15). This procedural gating means non‑compliance can delay or prevent a Court application, and a Court may refuse to confirm a scheme that does not meet statutory requirements under the Act (attachment table referencing 17C, 17E, 17F).

APRA supervisory actions and directions: Paragraph 2 records that a transfer or amalgamation can occur only under a scheme confirmed by the Federal Court unless it is undertaken in response to a direction from APRA. This indicates APRA has power to direct transfers under specific statutory circumstances in the Act; the Standard recognises such statutory powers rather than creating them (para 2). While the Standard does not itself list enforcement sanctions, APRA’s underlying statutory powers under the Insurance Act (and related prudential powers) provide administrative enforcement levers which sit outside the Standard’s text.

Post‑completion attestations and potential consequences for false statements: The Standard requires a director’s statutory declaration that sets out payments made and estimates and states a belief that no other payment has been made or will be made by, or with the knowledge of, a party to the transfer (para 18(1)(b)). Statutory declarations typically carry legal consequences (for example, liability for false statements under relevant law), though the Standard does not set out those consequences itself. The requirement creates an evidentiary record that could be used in regulatory or court proceedings if inaccuracies or undisclosed payments are later identified.

Time limits and APRA discretion: The transferee insurer must lodge specified documents within 30 days of completion (para 19). Insurers can apply for an extension, and APRA must, within 14 days, give a written extension of up to 30 days if APRA believes the insurer cannot reasonably provide the documents in time (para 20). APRA’s ability to withhold extensions can functionally enforce timely compliance.

Interaction with other statutes that carry sanctions: The Standard refers to the Insurance Acquisitions and Takeovers Act 1991 where notification obligations arise at a 15% threshold (para 3). IATA sets out its own compliance regime and potential penalties for failures to notify; those are separate statutes and not restated in the Standard, but the Standard’s note creates an enforcement interface.

Practical enforcement pathway: In summary, enforcement operates through (a) preclusion from accessing the Court confirmation process if APRA prerequisites are unmet, (b) APRA supervisory powers under the Insurance Act and potential directions, (c) statutory declaration obligations that may carry separate legal consequences if false, and (d) interaction with IATA where non‑notification could itself be actionable. The Standard delegates sanction and remedial power to the underlying legislative framework and to APRA’s regulatory discretion; the Standard primarily prescribes procedural preconditions and documentary obligations (paras 4-6; paras 18-20).

The Prudential Standard is explicitly designed to operate within and alongside the Insurance Act 1973 and the Insurance Acquisitions and Takeovers Act 1991, and it interfaces with Federal Court processes and statutory declaration regimes.

Insurance Act 1973: The Standard is issued under s 32 of the Insurance Act (instrument preamble). The attachment and tabular mapping link specific steps in the Standard to provisions in Part III, Division 3A of the Act, including ss 17C, 17D, 17E, 17F and 17I. For example, the requirement to provide a copy of the scheme and actuarial reports to APRA corresponds to 17C(2)(a) (attachment Order 1). The Standard repeatedly frames its procedural prerequisites in terms of those statutory sections (paras 4-6; paras 7-17; paras 18-20). The Standard therefore operationalises statutory procedures for Court confirmation of schemes.

APRA powers under the Act: The Standard contemplates APRA’s power to obtain or commission independent actuarial review under s 17D (attachment Order 1). It also recognises the statutory exception where an APRA direction can replace the need for a Court‑confirmed scheme (para 2). The Standard therefore does not create APRA’s supervisory powers but prescribes how APRA will exercise them in the context of transfer/amalgamation schemes.

Insurance Acquisitions and Takeovers Act 1991 (IATA): The Standard expressly states that transfers and amalgamations remain subject to IATA. When a transfer effectively amounts to acquisition of 15% or more of the transferring insurer’s premiums or outstanding claims liabilities, compulsory notification under IATA applies (para 3). That creates a parallel compliance obligation: an insurer must coordinate compliance with both the Standard and IATA notification procedures. The Standard does not reproduce IATA’s detail but flags the interaction.

Federal Court processes and discretion: The Standard makes the ability to lodge an application in the Federal Court conditional on compliance with APRA’s approval and publication requirements (paras 4-17). However, it expressly recognises the Court’s power to dispense with compliance with paragraph 17C(2)(c) of the Act (relating to providing the approved summary to policyholders); where the Court dispenses with that requirement, the earliest permitted date for application may be earlier than the standard 15‑day period (para 17). The Standard acknowledges the Court’s primacy in confirmation and respects judicial discretion.

Statutory declarations and other legislative regimes: The requirement for a director’s statutory declaration describing payments and estimates (para 18(1)(b)) interacts with statutory declaration laws and potential offences for false statements under relevant Commonwealth statutes. The Standard does not restate those offences but requires statements that will be subject to existing legislative obligations and scrutiny.

Corporate, tax and evidence law spillovers: While not specified in the Standard, the public disclosure and documentary requirements (publication on insurer websites, actuarial reports, asset/liability statements) will intersect with corporate reporting duties, confidentiality and privacy obligations, and potentially tax and securities laws where transfers affect corporate ownership or financial statements. The Standard itself focuses on prudential and public disclosure procedures and notes the need to ensure accessibility and prominence (para 16).

Regulatory sequencing and coordination risk: Because APRA approval of the summary and publication of scheme documents must occur before Court application and because IATA notifications may be required in parallel, insurers will need to coordinate approvals, notifications and timeframes across multiple statutes and decisionmakers. The attachment’s stepwise table maps those tasks to statutory references (attachment table Orders 1-7), signalling the sequencing insurers must follow.

In short, the Standard is not a standalone regime: it operationalises parts of the Insurance Act, integrates APRA’s supervisory instruments (including actuarial review power), and sits alongside IATA and Federal Court processes. Compliance therefore requires cross‑statute coordination and attention to judicial discretions referenced in the Act (paras 2-3; attachment).

The instrument revokes the previous Prudential Standard (Insurance (prudential standard) determination No. 1 of 2018 including Prudential Standard GPS 410 Transfer and Amalgamation of Insurance Business for General Insurers) and, under subsection 32(1) of the Insurance Act 1973, determines the new Prudential Standard GPS 410 in the form in the Schedule (instrument preamble). The instrument is dated 15 November 2025 and states the new Standard commences on 1 January 2026 (instrument preamble).

The text supplied does not record any prior amendments to the 2018 Standard, nor does it include a schedule of changes comparing the 2018 text with the incoming Standard. The instrument’s operative text contains the newly determined Standard and an attachment that maps tasks to provisions in the Insurance Act; it does not provide legislative history beyond revocation of the 2018 instrument.

Notable formalities recorded in the instrument:

• Authority: The new Standard is made under s 32 of the Insurance Act 1973 (instrument preamble; Standard para 1).
• Revocation: The prior Insurance (prudential standard) determination No. 1 of 2018, including the previous GPS 410, is expressly revoked (instrument preamble).
• Commencement: The Standard commences on 1 January 2026 (instrument preamble).
• Signing officer: The instrument is executed by Sean Carmody, a delegate of APRA, in his capacity as Executive Director, Policy and Advice Division (instrument preamble).

No other amendment entries, transitional provisions, savings clauses, or staged commencement dates are set out in the text supplied. The Standard itself prescribes operational steps and timing for scheme publication, Court application and post‑confirmation lodgements, but it does not set out transitional arrangements for schemes already in progress at the commencement date or for schemes that predate the revocation; the text supplied is silent on transitional treatment.

Because the instrument revokes the 2018 determination, insurers and advisers should treat the Standard as replacing the procedural rules previously contained in the revoked determination and should not assume continuity of any operational flexibility that may have existed under the prior instrument, unless APRA provides separate transitional guidance or the Act’s general transitional provisions apply. The attachment’s mapping to statutory sections suggests continuity in the statutory framework (ss 17C, 17D, 17E, 17F, 17I), but the exact differences between the revoked 2018 Standard and the new text are not in the supplied material.

Practitioners should monitor any APRA guidance or FAQs issued around the 1 January 2026 commencement to identify whether APRA will publish transitional instructions, expectations about ongoing schemes, or clarifications about APRA’s approval processes and the application of the new timing and publication requirements.

The text supplied contains no litigation history, case names, judicial decisions or citations. The Standard repeatedly delegates the confirmation of schemes to the Federal Court (para 2; paras 17 and the attachment referencing ss 17E and 17F), but it does not reference any Court decisions or precedent that interpret the statutory provisions or prior prudential standards.

What the instrument does specify about Court interaction:

• It states that a transfer or amalgamation of insurance business can occur only under a scheme confirmed by the Federal Court unless undertaken in response to an APRA direction (para 2). This establishes the Federal Court as the confirmation forum under the Act.
• It sets timing preconditions for making an application to the Federal Court (para 17), and it recognises the Court’s power to dispense with compliance with paragraph 17C(2)(c) of the Act (para 17). That clause implies that, in the absence of APRA approval or full compliance with the notice/delivery requirements, parties may seek judicial relief from procedural prerequisites in appropriate cases, but the Standard contains no guidance about the circumstances in which the Court has exercised or will exercise that discretion.

Because the Standard does not cite any judicial authorities, practitioners must rely on the statutory framework in Part III, Division 3A of the Insurance Act and on available Federal Court jurisprudence interpreting those statutory provisions and the mechanics of scheme confirmations. The attachment’s mapping to ss 17C through 17I indicates the relevant statutory provisions to research for case law, but the present document does not supply or reference any decided cases.

If litigation or contested confirmations occur in practice, the Court’s treatment of APRA’s role, the adequacy of APRA‑approved summaries, the sufficiency of actuarial reports (including APRA‑commissioned independent reviews under s 17D), and the consequences of non‑compliance with publication and timing requirements are likely to be the matters litigants and the Court will address. Those themes are inherent in the Standard’s procedural focus, but the text supplied contains no record of how courts have resolved such issues.

Timing traps and sequencing: The Standard makes the ability to apply to the Federal Court contingent on compliance with APRA’s pre‑publication requirements and specified waiting periods. An application may not be made earlier than the later of (a) one day after scheme documents have been published on the insurer’s website for at least 15 days, and (b) unless the Court dispenses, 15 days after the approved summary has been given to every affected policyholder (para 17). Failure to observe the sequencing , for example, publishing a notice of intention before APRA has approved the summary or applying to the Court before the publication window has closed , can render an application premature and subject to court rejection (paras 4-6; paras 7-11; para 17).

APRA approval is prior and substantive: APRA must approve the summary and the form of the notice of intention before publication (paras 7-11; paras 12-15). Insurers cannot unilaterally draft and send summaries without APRA’s sign‑off. Practically, this requires early engagement with APRA and time allocated for APRA review, particularly since APRA can arrange its own actuarial review under s 17D (attachment Order 1), which could extend timelines.

Website publication requirements: The scheme documents and actuarial reports must be accessible and prominently displayed on the websites of each insurer to be bound by the scheme from the time of the notice of intention until the confirmation hearing (para 16). Practitioners should ensure both (a) persistent public availability for the entire required period and (b) clear navigation and prominence so the publication is “reasonably prominent” and accessible. Simple posting in an obscure subpage may not satisfy the Standard.

Scope of “affected policyholders”: The Standard requires that the approved summary be given to “every affected policyholder” (para 12(1)). Determining who qualifies as an affected policyholder may be non‑trivial in group or portfolio transfers, or where policies are in runoff or administered offshore. Mistakes in identifying or delivering to affected policyholders could trigger compliance issues and potential court objections under the “interests of policyholders as a whole” test mentioned in the summary content (para 13(7)).

Statutory declaration wording: The director’s statutory declaration is prescriptive: it must set out each payment made, a reasonable estimate of each payment to be made, and state that the director reasonably believes no other payment has been or will be made by, or with the knowledge of, a party to the transfer or amalgamation (para 18(1)(b)(i)-(ii) and para 18(1)(b)(1)). This requires careful recordkeeping on payments and related‑party transactions. In particular, the declaration potentially captures contingent or indirect payments; advisers should ensure directors understand the breadth of the attestation and maintain documentary support.

IATA interaction at 15% threshold: Transfers that amount to acquisition of 15% or more of the transferring insurer’s premiums or outstanding claims liabilities trigger compulsory notification under the Insurance Acquisitions and Takeovers Act 1991 (para 3). Failing to consider IATA in transaction planning can mean parallel notification obligations are missed, leading to separate regulatory problems.

Court dispensation is possible but not guaranteed: The Court may dispense with compliance with paragraph 17C(2)(c) of the Act (relating to giving the approved summary to policyholders), which could shorten the waiting period for Court application (para 17). However, relying on a Court dispensation is risky and uncertain; insurers should treat it as an exceptional remedy rather than a planning assumption.

Post‑confirmation timing and extension mechanics: The transferee must lodge specified documents with APRA within 30 days of completion (para 19). Although an extension up to 30 days is available, insurers must apply for that extension in writing before the 30‑day period expires, and APRA has 14 days to respond (para 20). Late or retroactive applications for extension are not provided for in the text supplied, so administrative calendaring is critical.

Actuarial report content and APRA review: The Standard requires actuarial reports to accompany the scheme and to be published (paras 4-6; para 16). APRA’s ability to commission an independent actuarial review under s 17D (attachment) raises the prospect that APRA’s review could surface issues, require remedial steps, or delay progression to Court. Allocating time and resources for potential independent reviews is prudent.

Public visibility and market reactions: The requirement to publish schemes and actuarial reports publicly and prominently (para 16) means market participants, rating agencies, reinsurers and competitors will have access to potentially sensitive commercial information. Insurers should plan communications, confidentiality protections where lawful, and stakeholder engagement to manage reputational and commercial impacts.

No express penalty language in the Standard: Because the Standard does not set out express statutory penalties in the text supplied, parties might misconceive that non‑compliance is consequence‑free. In reality, the primary enforcement mechanism is denial of entitlement to seek Court confirmation coupled with APRA’s statutory powers and the legal consequences of false statutory declarations (paras 4-6; paras 18-20). Do not assume compliance failures are immaterial.

A practical, source‑aligned checklist and recommended steps, mapped to the Standard’s paragraphs and the attachment’s task table:

1. Early engagement with APRA

   • Before drafting the notice of intention or distributing any summary to policyholders, engage APRA and provide a copy of the proposed scheme and any actuarial reports so APRA can review and approve the summary, and, if necessary, commission an independent actuarial review under s 17D (paras 4-6; attachment Order 1). Early contact reduces the risk of rework and timing delays.

2. Prepare scheme documents and actuarial reports

   • Ensure the scheme documentation and the actuarial reports are complete, audited for technical accuracy, and ready for APRA review. APRA must receive these documents before a notice of intention is published and before an approved summary is given to policyholders (paras 4-6).

3. Draft an APRA‑compliant approved summary

   • Draft the summary to cover the minimum content the Standard requires: identity and contact details of the transferee insurer, the proposed transfer date, the effect of the transfer on rights and liabilities, any actions policyholders must take (or confirmation that no action is needed), how to obtain more information, that policyholders may attend and request to be heard by the Federal Court, and any proposed changes to terms and conditions (paras 12-15). If the summary is to be accompanied by an insurer letter, the letter must highlight that the APRA‑approved summary contains essential information (para 12(2)).

4. Obtain APRA approval of the summary and notice

   • Submit the proposed approved summary and the notice of intention to APRA for approval prior to publication (paras 7-11; paras 12-15). Factor in potential APRA requests for additional information or time for an independent actuarial review.

5. Publish notice of intention and scheme documents

   • Once APRA approval is obtained, publish the notice of intention in the APRA‑approved form and ensure it is accessible and reasonably prominent (paras 7-11). Simultaneously publish a copy of the scheme and the actuarial reports on the websites of each insurer to be bound by the scheme, ensuring visibility and persistent access from the time of publication up to the date of the confirmation hearing (para 16).

6. Deliver the approved summary to every affected policyholder

   • Send the APRA‑approved summary to every affected policyholder before or at the same time the scheme is published (para 12(1); final sentence of para 15). Maintain reliable proof of delivery and records identifying policyholders considered “affected.”

7. Observe the waiting periods before Court application

   • Do not apply to the Federal Court earlier than: a) one day after the scheme documents have been published on the insurer’s website for at least 15 days; and b) unless the Court dispenses with compliance, 15 days after the approved summary has been given to every affected policyholder (para 17). Where a Court dispensation is contemplated, be prepared to justify urgency and to accept judicial discretion.

8. Coordinate IATA notifications where relevant

   • If the transfer amounts to acquisition of 15% or more of the transferring insurer’s premiums or outstanding claims liabilities, comply with the compulsory notification requirements under the Insurance Acquisitions and Takeovers Act 1991 (para 3). Plan parallel submissions and timings.

9. Prepare for APRA’s post‑confirmation lodgements

   • If the Court confirms the scheme and the transfer or amalgamation completes, the transferee insurer must lodge with APRA within 30 days: a) certified copies of the scheme and the Court order; b) a statement of the assets and liabilities of each insurer before and after the transfer; and c) a statutory declaration by a director setting out each payment made, reasonable estimates of payments to be made, and a statement the director reasonably believes no other payment has been or will be made by, or with the knowledge of, a party to the transfer (paras 18-19). Prepare these documents in advance to avoid late lodgement.

10. Apply for an extension if necessary, early

    • If realistically unable to meet the 30‑day deadline for post‑completion lodgements, apply in writing to APRA before the 30 days expire. APRA must respond within 14 days and may grant an extension of up to 30 days (para 20). Do not assume late application will be accepted; apply proactively.

11. Governance and director assurances

    • Maintain detailed records of all payments, consideration and related‑party transactions connected to the transfer to support the director’s statutory declaration (para 18(1)(b)). Ensure boards and audit committees are briefed and that directors authorised to sign statutory declarations have access to appropriate evidence and legal advice.

12. Publication and communications controls

    • Because scheme documents and actuarial reports will be publicly available on insurer websites (para 16), coordinate communications, market disclosures and confidentiality assessments beforehand. Redact only where legally permissible and consistent with APRA guidance.

13. Document retention and audit trail

    • Keep clear audit trails of communications with APRA, proof of delivery to policyholders, website publication screenshots, and versions of the APRA‑approved summary and notice for any later court scrutiny.

14. Legal and actuarial advice

    • Engage independent legal and actuarial advisers early to prepare compliant scheme documentation and actuarial reports expected by APRA and the Court, and to anticipate APRA’s potential independent review under s 17D (attachment).

Following the Standard’s prescribed sequence (attachment table Orders 1-7 and paras 4-20) and maintaining an APRA‑first posture for approvals substantially reduces execution risk. Early and thorough documentation, proof of communication to affected policyholders, and robust director‑level records for the statutory declaration are practical necessities under the Standard.